Sedation in pediatric imaging using intranasal midazolam
- 120 Downloads
Intranasal midazolam offers an attractive alternative for use as a sedative agent for medical imaging studies in children. Its convenient administration and rapid onset are significant advantages over intravenous and oral agents. Because of its short duration, it is effective only for short procedures and as an adjunct to other sedative agents. When younger children present with such requirements, a dose of 0.2 mg/kg has been safe and effective in our experience. We advocate its use with adherence to guidelines for sedation published by the American Academy of Pediatrics.
Unable to display preview. Download preview PDF.
- 1.American Academy of Pediatrics, Committee on Drugs (1988) Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 89: 1110–1115Google Scholar
- 3.Rochette A, Julia JM, Evrard O, et al (1984) Intramuscular premedication with midazolam in infants and children. Ann Fr Anesth Réanim 3: 346–350Google Scholar